Skip to content

Clinical trials

Lymphoproliferative Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20112
20122
20131
20151
20171
20181
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group4
Acerta Pharma BV1
Amgen Research (Munich) GmbH1
Ariad Pharmaceuticals1
Pierre Fabre Medicament1
Radiation Therapy Oncology Group1
Spectrum Pharmaceuticals, Inc1
St. Justine's Hospital1
Sunnybrook Health Sciences Centre1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders14
Lymphoma7
Lymphoma, Non-Hodgkin6
Neoplasms6
Lymphatic Diseases5
Immunoproliferative Disorders4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, T-Cell, Cutaneous4
Burkitt Lymphoma3
Immune System Diseases3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.